Acro Biomedical Co annual operating margin
2017
2018
2019
2019
2020
2021
2022
Acro Biomedical Co's operating margin was −2,409.98% for fiscal 2022.
View full Acro Biomedical Co company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −2,409.98% | −1767.51 pp |
| 2021 | 2021-12-31 | −642.47% | −623.51 pp |
| 2020 | 2020-12-31 | −18.96% | +199.47 pp |
| 2019 · Dec 31 | 2019-12-31 | −218.44% | −185.82 pp |
| 2019 · Sep 30 | 2019-09-30 | −32.61% | −39.04 pp |
| 2018 | 2018-09-30 | 6.43% | +6.87 pp |
| 2017 | 2017-09-30 | −0.44% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2022 | 2022-12-31 | −1,092.75% | −1035.47 pp |
| Q1 2022 | 2022-03-31 | −1,316.11% | −1327.96 pp |
| Q4 2021 | 2021-12-31 | −644.25% | −650.94 pp |
| Q2 2021 | 2021-06-30 | −158.66% | −166.68 pp |
| Q1 2021 | 2021-03-31 | −57.28% | −62.27 pp |
| Q1 2020 | 2020-03-31 | 11.85% | +6.30 pp |
| Q4 2018 | 2018-09-30 | 6.69% | — |
| Q3 2018 | 2018-06-30 | 8.01% | — |
| Q2 2018 | 2018-03-31 | 4.99% | — |
| Q1 2018 | 2017-12-31 | 5.55% | — |
Over the last five reported fiscal years, Acro Biomedical Co's operating margin decreased from 6.43% to −2,409.98%, a change of −2416.42 percentage points. The latest reported quarter, Q4 2022, shows −1,092.75%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Acro Biomedical Co filings at SEC.gov ↗